Thank you, Mr. Chairman.
Dr. Sanders, a few moments ago, in your opening statement, you recognized that the process could be changed or improved. You said that we should work together to make these improvements and address these situations in a less antagonistic way.
I was just wondering how you would like all stakeholders to think more serenely and positively about these things, when you said in your statement that what other witnesses had told us was wrong, and that you wanted to set the record straight. I am convinced that if we were to call back the people who already appeared before us, they would perhaps also say that you are wrong.
Given everything we have heard so far about the drug review process and the process to recognize their effectiveness, we get the feeling that it will be difficult to find a common ground. I am simply wondering what solutions you have in mind to get everyone to pull in the same direction to provide patients in need with the best possible drugs, since they are probably the ones who are suffering the consequences of these disputes, arguments and misunderstandings.